The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning

被引:38
作者
Gonzalez, M
Quezada, SA
Blazar, BR
Panoskaltsis-Mortari, A
Rudensky, AY
Noelle, RJ
机构
[1] Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
[2] Univ Minnesota, Div Bone Marrow Transplantat, Minneapolis, MN 55455 USA
[3] Univ Washington, Howard Hughes Inst, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.169.10.5581
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Graft-vs-host disease (GVHD) remains the most life-threatening complication following the transfer of allogeneic bone marrow into immunocompromised hosts. Transferred alloreactive T cells respond in a complex manner. While massive T cell expansion is observed upon entry into an allogeneic environment, anergy, apoptosis, and repertoire selection are also observed. The study presented here shows that alloreactive T cell expansion and differentiation vs anergy and suppression are dramatically influenced by host conditioning. Using alloreactive CD4(+) and CD8(+) TCR transgenic (Tg) T cells, a novel GVHD model is presented that allows for the visualization of how alloreactive T cells behave when host conditioning is manipulated. Following the transfer of alloreactive CD4(+) and CD8(+) TCR Tg T cells into sublethally irradiated hosts, both Tg T cells populations expand, develop effector function, and cause GVHD. In contrast, when Tg T cells are transferred in non-irradiated hosts, expansion is observed, but there is no development of effector function or disease. Assessment of CD4(+) Tg T cell function following transfer into non-irradiated hosts reveals that these CD4(+) Tg cells are profoundly anergic and have acquired a regulatory function, as manifested in their ability to suppress the expansion of naive TCR Tg T cells in vitro and in vivo as well as the development of GVHD. These findings underscore the decisive effect of the inflammatory environment created by irradiation in determining the ultimate fate and function of alloreactive T cells in vivo.
引用
收藏
页码:5581 / 5589
页数:9
相关论文
共 39 条
[1]   CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].
Adler, AJ ;
Marsh, DW ;
Yochum, GS ;
Guzzo, JL ;
Nigam, A ;
Nelson, WG ;
Pardoll, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1555-1564
[2]   ANTI-CD4 MEDIATES CLONAL ANERGY DURING TRANSPLANTATION TOLERANCE INDUCTION [J].
ALTERS, SE ;
SHIZURU, JA ;
ACKERMAN, J ;
GROSSMAN, D ;
SEYDEL, KB ;
FATHMAN, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) :491-494
[3]   Negative selection during the peripheral immune response to antigen [J].
Anderton, SM ;
Radu, CG ;
Lowrey, PA ;
Ward, ES ;
Wraith, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (01) :1-11
[4]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[5]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[6]   Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer [J].
Blazar, BR ;
Taylor, PA ;
McElmurry, R ;
Tian, L ;
Panoskaltsis-Mortari, A ;
Lam, S ;
Lees, C ;
Waldschmidt, T ;
Vallera, DA .
BLOOD, 1998, 92 (10) :3949-3959
[7]  
Blazar BR, 1997, J IMMUNOL, V158, P29
[8]   Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease [J].
Brochu, S ;
Rioux-Massé, B ;
Roy, J ;
Roy, DC ;
Perreault, C .
BLOOD, 1999, 94 (02) :390-400
[9]  
Buhlmann JE, 1999, J IMMUNOL, V162, P4373
[10]   CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation [J].
Chai, JG ;
Vendetti, S ;
Amofah, E ;
Dyson, J ;
Lechler, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3037-3042